AAL vs RARE · P/E 11, rev $30.65B vs rev $350.0M
American Airlines Group (AAL) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
American Airlines Group (AAL) is a airlines company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AAL revenue for 2026-06-30 was $30.65B. Net income was -$311.0M. AAL currently screens at market cap $7.34B and trailing P/E 11.1.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AAL currently screens at market cap $7.34B and trailing P/E 11.1. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AAL and RARE stock pages for the full models.
Not investment advice.